Lactoferrin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

The Global lactoferrin market is expected to expand from USD 148.39 million in 2025 to USD 249.14 million by 2031, representing a compound annual growth rate of 9.02%. This 80 kDa iron-binding glycoprotein, found naturally in mammalian milk and other bodily secretions, is highly valued for its extensive biological functions, which include immunomodulatory, anti-inflammatory, antiviral, and antimicrobial effects. Market growth is heavily fueled by rising consumer knowledge of its health advantages, especially concerning improved iron uptake and immune system support. Additionally, the increasing use of lactoferrin in pharmaceuticals, dietary supplements, functional foods, and infant formula - where it replicates elements of human breast milk - greatly contributes to the industry's upward trajectory.

Even with these positive growth factors, the worldwide lactoferrin industry encounters a significant hurdle due to the steep expenses involved in extracting and purifying the compound from natural sources. These complex procedures demand highly specialized equipment and technology, which ultimately restricts both the scalability and affordability of the end products. Highlighting the raw material requirements of this manufacturing process, the USDA Foreign Agricultural Service noted that fluid milk production in New Zealand reached an estimated 21.7 million metric tons for the 2025 market year, with a substantial share allocated to creating value-added dairy components like lactoferrin.

Market Driver

Growing consumer knowledge regarding the health advantages of lactoferrin is significantly shaping the industry by driving the need for nutritionally enriched and immune-boosting goods. A strong emphasis on ingredient excellence and preventive health measures has led manufacturers to develop items that utilize the established benefits of this glycoprotein. Highlighting this trend, a January 2025 report from FrieslandCampina Ingredients revealed that more than 59% of parents with infants under twelve months old wanted to enhance their child's immune system, prompting the addition of these helpful ingredients into dietary products. This strong buyer enthusiasm is pushing lactoferrin beyond conventional supplements and into the realm of functional beverages and foods, diversifying its practical uses.

Another major catalyst for market growth is the escalating need for lactoferrin in baby formula, driven by its capacity to enhance iron absorption, bolster infant immunity, and replicate components found in breast milk. This surge has led to substantial financial backing for manufacturing and innovation within the sector. As reported by Mejerimedier in September 2024, Arla Foods is enlarging its HOCO facility in Holstebro, Denmark, where construction starting in 2025 will yield a new plant capable of boosting powder output by roughly 180 kg daily to specifically increase lactoferrin eluate production. Emphasizing wider market optimism regarding early life nutrition demands, cellular agriculture investment firm Agronomics injected an additional AUD 3 million into Australian biotechnology company All G in January 2026 as part of a larger AUD 10 million funding initiative aimed at scaling up precision fermentation-based lactoferrin production.

Market Challenge

Elevated manufacturing expenses present a formidable obstacle to the expansion of the worldwide lactoferrin industry. Extracting and refining this ingredient from its primary natural source, mammalian milk, involves complex procedures that demand significant financial backing and highly specialized technological equipment. Consequently, the high costs are passed down to lactoferrin-infused items, reducing their affordability and restricting their reach among wider audiences, especially within demographics highly sensitive to pricing. Additionally, because the extraction techniques are so specialized, scaling up operations is constrained by the need for advanced facilities and massive capital investments.

The International Dairy Federation noted in its 2025 World Dairy Situation Report that the worldwide output of raw, unprocessed milk across all species increased by 2.2% during 2024. Even though this points to an expanding supply of foundational raw materials, the fundamental difficulties and steep expenses associated with extracting a highly pure component like lactoferrin from such vast quantities remain a major hurdle. These enduring operational complexities make it difficult to achieve cost-effective mass production, ultimately slowing down the broader growth potential of the market.

Market Trends

A prominent trend in the industry is the incorporation of lactoferrin into personal care items and cosmeceuticals, a shift motivated by a deepening scientific grasp of its varied biological functions. The ingredient is becoming increasingly attractive for oral care, haircare, and skincare formulations as ongoing studies reveal its potent antioxidant, anti-inflammatory, and antimicrobial traits. Producers are capitalizing on its natural derivation and versatile advantages to formulate solutions for diverse dermatological issues, spanning from anti-aging treatments to acne management. This transition into beauty and wellness sectors is supported by extensive research; as noted on the Morinaga Milk Industry website in December 2025, more than 9,000 global scientific publications now document lactoferrin's broad capabilities and uses outside of standard nutritional applications.

At the same time, the industry is being transformed by a surging consumer appetite for animal-free lactoferrin, driven by a desire for hypoallergenic, ethically sourced, and sustainable components. The use of precision fermentation technology plays a crucial role in creating lactoferrin without relying on animal origins, providing a reliable and scalable substitute for conventional bovine extraction. This movement is drawing significant financial investment and unlocking novel market avenues as businesses strive to align with modern shoppers' ethical and dietary preferences. Illustrating this commercial momentum, a January 2025 FoodNavigator-USA report noted that Strive Nutrition planned to introduce a ready-to-mix protein powder and a functional beverage featuring TurtleTree's animal-free lactoferrin in the first quarter of 2025, highlighting the strong market readiness for these cutting-edge alternatives.

Key Market Players

• Hilmar Cheese Co Inc
• Pharming Group NV
• Royal FrieslandCampina N.V.
• Synlait Milk Ltd
• Ingredia SA
• MP Biomedicals LLC
• Tatura Milk Industries Ltd
• Glanbia PLC
• APS BioGroup Inc
• ProHealth Care Inc

Report Scope

In this report, the Global Lactoferrin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lactoferrin Market, By Function:

• Iron Absorption
• Anti-inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

Lactoferrin Market, By Application:

• Food & Beverages
• Infant Formula
• Sports & Functional Foods
• Pharmaceuticals
• Personal Care Products
• Animal Feed

Lactoferrin Market, By Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lactoferrin Market.

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.